[125I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors

被引:14
作者
Wu, Jinhua [1 ]
Perry, David C. [2 ]
Bupp, James E. [3 ]
Jiang, Faming [4 ]
Polgar, Willma E. [3 ]
Toll, Lawrence [1 ]
Zaveri, Nurulain T. [4 ]
机构
[1] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA
[2] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20037 USA
[3] SRI Int, Menlo Pk, CA 94025 USA
[4] Astraea Therapeut, Mountain View, CA 94043 USA
基金
美国国家卫生研究院;
关键词
Nicotinic acetylcholine receptor; Alpha3beta4; AT-1012; Receptor binding; In vitro autoradiography; INTERPEDUNCULAR NUCLEUS; COMPARATIVE PHARMACOLOGY; CHOLINERGIC-RECEPTORS; MOUSE-BRAIN; BINDING; RAT; 18-METHOXYCORONARIDINE; EPIBATIDINE; NULL; IBOGAINE;
D O I
10.1016/j.neuropharm.2013.09.023
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent genetic and pharmacological studies have implicated the alpha 3, beta 4 and alpha 5 subunits of the nicotinic acetylcholine receptor (nAChR) in dependence to nicotine and other abused drugs and nicotine withdrawal. The alpha 3 beta 4* nAChR subtype has been shown to co-assemble with the alpha 5 or beta 3 nAChR subunits, and is found mainly in the autonomic ganglia and select brain regions. It has been difficult to study the alpha 3 beta 4 nAChR because there have been no selective nonpeptidic ligands available to independently examine its pharmacology. We recently reported the synthesis of a [I-125]-radiolabeled analog of a high affinity, selective small-molecule alpha 3 beta 4 nAChR ligand, AT-1012. We report here the vitro characterization of this radioligand in receptor binding and in vitro autoradiographic studies targeting the alpha 3 beta 4* nAChR. Binding of [I-125]AT-1012 was characterized at the rat alpha 3 beta 4 and alpha 4 beta 2 nAChR transfected into HEM cells, as well as at the human alpha 3 beta 4 alpha 5 nAChR in HEK cells. Binding affinity of [I-125]AT-1012 at the rat alpha 3 beta 4 nAChR was 1.4 nM, with a B-max of 10.3 pmol/mg protein, similar to what was determined for unlabeled AT-1012 using [H-3]epibatidine. Saturation isotherms suggested that [I-125]AT-1012 binds to a single site on the alpha 3 beta 4 nAChR. Similar high binding affinity was also observed for [I-125]AT-1012 at the human alpha 3 beta 4 alpha 5 nAChR transfected into HEM cells. [I-125]AT-1012 did not bind with high affinity to membranes from alpha 4 beta 2 nAChR-transfected HEM cells. Binding studies with [3H]epibatidine further confirmed that AT-1012 had over 100-fold binding selectivity for alpha 3 beta 4 over alpha 4 beta 2 nAChR. K-i values determined for known nAChR compounds using [I-125]AT-1012 as radioligand were comparable to those obtained with [H-3]epibatidine. [I-125]AT-1012 was also used to label alpha 3 beta 4 nAChR in rat brain slices in vitro using autoradiography, which showed highly localized binding of the radioligand in brain regions consistent with the discreet localization of the alpha 3 beta 4 nAChR. We demonstrate that [I-125]AT-1012 is an excellent tool for labeling the alpha 3 beta 4 nAChR in the presence of other nAChR subtypes. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 32 条
  • [1] An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants
    Baddick, Christopher G.
    Marks, Michael J.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 828 - 841
  • [2] BADIO B, 1994, MOL PHARMACOL, V45, P563
  • [3] α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking
    Berrettine, W.
    Yuan, X.
    Tozzi, F.
    Song, K.
    Francks, C.
    Chilcoat, H.
    Waterworth, D.
    Muglia, P.
    Mooser, V.
    [J]. MOLECULAR PSYCHIATRY, 2008, 13 (04) : 368 - 373
  • [4] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [5] DavilaGarcia MI, 1997, J PHARMACOL EXP THER, V282, P445
  • [6] GERZANICH V, 1995, MOL PHARMACOL, V48, P774
  • [7] 18-MC reduces methamphetamine and nicotine self-administration in rats
    Glick, SD
    Maisonneuve, IM
    Dickinson, HA
    [J]. NEUROREPORT, 2000, 11 (09) : 2013 - 2015
  • [8] 18-methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats
    Glick, SD
    Ramirez, RL
    Livi, JM
    Maisonneuve, IM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 537 (1-3) : 94 - 98
  • [9] Modulation of nicotine self-administration in rats by combination therapy with agents blocking α3β4 nicotinic receptors
    Glick, SD
    Maisonneuve, IM
    Kitchen, BA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 448 (2-3) : 185 - 191
  • [10] 18-methoxycoronaridine (18-MC) and ibogaine - Comparison of antiaddictive efficacy, toxicity, and mechanisms of action
    Glick, SD
    Maisonneuve, IM
    Szumlinski, KK
    [J]. NEUROBIOLOGICAL MECHANISMS OF DRUGS OF ABUSE: COCAINE, IBOGAINE, AND SUBSTITUTED AMPHETAMINES, 2000, 914 : 369 - 386